(Q34679612)

3 August 2017

1 reference

title

Interactions between drugs for erectile dysfunction and drugs for cardiovascular disease (English)

1 reference

3 August 2017

main subject

cardiovascular disease

1 reference

1 reference

Simonsen U

1

1 reference

3 August 2017

language of work or name

1 reference

1 June 2002

1 reference

International Journal of Impotence Research

3 August 2017

published in

1 reference

3 August 2017

volume

14

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

178-188

1 reference

Psychosocial outcome after coronary artery surgery.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Multiple risk factors and population attributable risk for ischemic heart disease mortality in the United States, 1971-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Relationship of penile brachial pressure index to myocardial infarction and cerebrovascular accidents in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Adverse drug effects, compliance, and initial doses of antihypertensive drugs recommended by the Joint National Committee vs the Physicians' Desk Reference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

The effects of antihypertensive therapy on the quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Bisoprolol and Hypertension: Effects on Sexual Functioning in Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Calcium antagonists stimulate sperm motility in ejaculated human semen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Erectile dysfunction in hypertensive subjects. Assessment of potential determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

ABC of heart failure. Management: diuretics, ACE inhibitors, and nitrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

The rational use of beta-adrenoceptor blockers in the treatment of heart failure. The changing face of an old therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

A possible mechanism for alteration of human erectile function by digoxin: inhibition of corpus cavernosum sodium/potassium adenosine triphosphatase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Contribution of K+ channels and ouabain-sensitive mechanisms to the endothelium-dependent relaxations of horse penile small arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Possible role of Na(+)-K(+)-ATPase in the regulation of human corpus cavernosum smooth muscle contractility by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

The effect of long-term administration of digoxin on plasma androgens and sexual dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Impotence in patients treated with clofibrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

PPARalpha-dependent induction of liver microsomal esterification of estradiol and testosterone by a prototypical peroxisome proliferator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Central nervous system effects of HMG CoA reductase inhibitors: lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Simvastatin seems unlikely to cause impotence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Assessment of erectogenic properties of apomorphine and yohimbine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Key issues from the clinical trials of apomorphine SL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Dopamine receptor pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Cardiovascular safety of sublingual apomorphine in patients on stable doses of oral antihypertensive agents and nitrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction. The Apomorphine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Apomorphine potentiates vagal bradycardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Effects of SK&F 85174, a DA-1/DA-2 receptor agonist, on pre- and postganglionic sympathetic neurotransmission to the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

The pharmacology and clinical pharmacokinetics of apomorphine SL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Phentolamine mesylate relaxes penile corpus cavernosum tissue by adrenergic and non-adrenergic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Oral alpha adrenoceptor blockade as a treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Prazosin first dose phenomenon during combined treatment with a beta-adrenoceptor blocker in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Yohimbine: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Modulation of sexual behaviour in the rat by a potent and selective alpha 2-adrenoceptor antagonist, delequamine (RS-15385-197).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Herbs and alternative therapies in the hypertension clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Effect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clomipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Sildenafil: a review of its use in erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Sildenafil citrate (Viagra) does not exacerbate myocardial ischemia in canine models of coronary artery stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Sildenafil inhibits hypoxia-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Inhibition of neuroeffector transmission in human vas deferens by sildenafil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Cardiac electrophysiologic and hemodynamic effects of sildenafil, a PDE5 inhibitor, in anesthetized dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Relationship Between Cavernosal Ischemia and Corporal Veno-Occlusive Dysfunction in an Animal Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

YOHIMBINE FOR ERECTILE DYSFUNCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Male sexual dysfunction associated with coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Cigarette smoking and other vascular risk factors in vasculogenic impotence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

The prevalence and etiology of impotence in 101 male hypertensive outpatients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Diuretic therapy for mild hypertension: the "real" cost of treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Physiology of penile erection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Adrenoceptor-mediated regulation of the contractility in horse penile resistance arteries

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Moxisylyte: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in impotence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Erectile dysfunction due to atherosclerotic vascular disease: the development of an animal model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Nitric oxide and penile erection in streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

The penis is not protected--in hypertension there are vascular changes in the penis which are similar to those in other vascular beds

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Morphological changes in cavernous tissue in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Gemfibrozil-induced impotence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Men treated with hypolipidaemic drugs complain more frequently of erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Preservation of potency after treatment for priapism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Effect of apomorphine on penile tumescence in men with psychogenic impotence.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Recovery of erectile function by the oral administration of apomorphine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Effects of intrathecal and systemic administration of buspirone on genital reflexes and mating behavior in male rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Acute myocardial infarction associated with sildenafil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Hemodynamic effects of sildenafil in men with severe coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Effects of sildenafil citrate (Viagra) combined with nitrate on the heart

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Effect of sildenafil citrate on blood pressure and heart rate in men with erectile dysfunction taking concomitant antihypertensive medication. Sildenafil Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Sildenafil (Viagra) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Anion and cation modulation of the guinea-pig ventricular action potential during beta-adrenoceptor stimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Interaction of sildenafil and indinavir when co-administered to HIV-positive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Overall cardiovascular profile of sildenafil citrate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Double-blind multicenter study comparing alprostadil alpha-cyclodextrin with moxisylyte chlorhydrate in patients with chronic erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Intracavernous Alprostadil Alfadex--an effective and well tolerated treatment for erectile dysfunction. Results of a long-term European study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Minimally invasive therapies in the treatment of erectile dysfunction in anticoagulated cases: a study of satisfaction and safety

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900846

7 January 2021

Identifiers

DOI

10.1038/SJ.IJIR.3900846

1 reference

Dimensions Publication ID

3 August 2017

1002365145

0 references

1 reference